Insider Trading & Ownership - Hannah Brendan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hannah Brendan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-19
Purchase
2024-08-21
6:38 pm
Quince Therapeutics Inc.QNCXHannah Brendan
CHIEF BUSINESS OFFICER AND COO
38,924$0.62085$24,166296,540
(Direct)
View
2023-08-08
Purchase
2023-08-09
6:21 pm
Quince Therapeutics Inc.QNCXHannah Brendan
Chief Business Officer
71,762$1.22$87,550201,555
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-04
Exercise
2024-06-05
2:37 pm
N/A
N/A
Quince Therapeutics Inc.QNCXHannah Brendan
CHIEF BUSINESS OFFICER AND COO
56,061$0.55305,055
(Direct)
View
2024-06-04
Exercise
2024-06-05
2:37 pm
N/A
2032-03-27
Quince Therapeutics Inc.QNCXHannah Brendan
CHIEF BUSINESS OFFICER AND COO
56,061$0305,055
(Direct)
View
2024-02-01
Option Award
2024-02-02
5:53 pm
N/A
2034-01-31
Quince Therapeutics Inc.QNCXHannah Brendan
CHIEF BUSINESS OFFICER AND COO
600,000$0600,000
(Direct)
View
2023-10-24
Option Award
2023-10-26
5:54 pm
N/A
2033-10-23
Quince Therapeutics Inc.QNCXHannah Brendan
Chief Business Officer and COO
75,000$075,000
(Direct)
View
2023-02-01
Option Award
2023-02-02
6:29 pm
N/A
2033-01-31
Quince Therapeutics Inc.QNCXHannah Brendan
Chief Business Officer
225,000$0225,000
(Direct)
View
2022-05-19
Option Award(A)
2022-05-27
5:34 pm
N/A
N/A
Cortexyme Inc.CRTXHannah Brendan
Chief Business Officer
113,569$0129,793
(Direct)
View
2022-05-19
Option Award
2022-05-23
8:07 pm
N/A
2032-03-27
Cortexyme Inc.CRTXHannah Brendan
Chief Business Officer
473,380$0473,380
(Direct)
View
(A) Indicate amendment filing.